Searched for
ALEMBIC TECHNOLOGIES
These mid-cap stocks with ‘Strong Buy’ & ‘Buy’ recos can rally over 27%, according to analystsWe are in a phase in the US-Israel-Iran war where statements are made, then retracted. And, in a matter of just 48 hours, they are made all...- These mid-cap stocks with ‘Strong Buy’ & ‘Buy’ recos can rally over 25%, according to analystsThe latest escalation in the US-Iran war means that crude oil price is back as a risk for India. Although we are in a market already strugg...
- More macro headwinds on the cards? Tackle them with core principles: 6 pharma stocks with upside potential of up to 28%There was a time when the Indian pharma story in the US was almost entirely about inspection risk. The US FDA would inspect a plant, a warn...
- These mid-cap stocks with ‘Strong Buy’ & ‘Buy’ recos can rally over 25%, according to analystsIn the stock market, everything has to be seen in context. The most noticeable thing these past few days is that there is not much Gulf-rel...
- Wealth creation is also about ignoring noise on the street: 15 mid- and small-cap stocks from different sectors which fit the billIn the April 2022-September 2024 bull market, every management appeared capable. Margins expanded, working capital looked manageable, capit...
- These mid-cap stocks with ‘Strong Buy’ & ‘Buy’ recos can rally over 25%, according to analystsWhat we are witnessing in the market these days is similar to scenarios that have played out in the past. There have been many points in th...
- Sun Pharma deal: Perception changer for Indian pharma sector? 10 pharma stocks with upside potential of up to 38%The Indian pharma sector made its initial global forays almost a quarter century ago. Companies sought out markets abroad, learnt to deal w...
- These mid-cap stocks with ‘Strong Buy’ & ‘Buy’ recos can rally over 25%, according to analystsWhat is evident in the last few trading sessions is how the street is treating Q4 earnings numbers. If a company delivers in terms of numbe...
- These mid-cap stocks with ‘Strong Buy’ & ‘Buy’ recos can rally over 25%, according to analystsThe markets should be in a happy frame of mind till the time the current ceasefire in the Gulf region holds. Not many may like us using the...
- Google expands footprint in Alembic City to 2.6 million sq ftGoogle is significantly expanding its presence in Bengaluru's Whitefield. The tech giant has secured rights for approximately 2.6 million s...
- Stocks in news: HFCL, BHEL, Glenmark Pharma, ABFRL, WiproPiramal Enterprises Board approved the issuance of secured, rated, listed, and redeemable non-convertible debentures (NCDs) worth up to Rs ...
- Stocks in news: Ultratech, Paytm, L&T, Biocon, Alembic PharmaLarsen and Toubro (L&T) has overturned a Rs 702 crore customs duty demand following a favourable ruling from the Central Excise & Service T...
- Alembic Pharma buys out partner stake in Aleor DermaceuticalsAleor has product offerings across cream, gel, ointment, shampoo, lotion, solutions, sprays, foams, microsponge and nanoparticulate platfor...
- Alembic Pharma JV Aleor Dermaceuticals gets USFDA nod for testosterone topical solutionAleor Dermaceuticals has received final approval from the US Food and Drug Administration (USFDA) for its abbreviated new drug application ...
- Alembic, Mphasis, Granules and 3 others in F&OThe futures and options contracts on these six securities would be available for trading with effect from February 26, the exchange said.
- Alembic Pharma gets USFDA nod for anti-viral drugQuoting IQVIA data, Alembic Pharma said Amantadine Hydrochloride Tablets, 100 mg have an estimated market size of USD 13 million for twelve...
- Faultless succession plan key to survival of family businesses“Only business houses that have mastered the art of succession planning, and those that have instilled family values among young inheritors...
- Alembic Pharma jumps 3% as JV firm completes USFDA inspectionAlembic Pharma manufactures and markets generic pharmaceutical products across the globe.
- Alembic-Orbicular Pharma JV to develop, manufacture dermatology products"APL and Orbicular will own 60 per cent and 40 per cent of the equity capital of Aleor when the transaction is completed," the Vadodara-bas...
- Alembic signs licensing agreement with UCBAlembic today said it has signed $11 million licensing agreement with Belgium-based UCB for anti-epileptic drug Keppra.
Load More
